Infective endocarditis and COVID -19 coinfection: An updated review

Acta Biomed. 2022 Mar 14;93(1):e2022030. doi: 10.23750/abm.v93i1.10982.

Abstract

With the rising number of COVID-19 patients, there have been reports of patients presenting with concomitant infective endocarditis. In this retrospective review, we included all articles from Medline with COVID-19 and infective endocarditis coinfection. Ten articles were identified from eight different countries over the world over the past 11 months. All patients reported with the above coinfections were male with a mean age of 53 years. Clinical features of COVID-19 and the presence of ground-glass opacity in CT thorax were predominant among patients with positive RT-PCR for COVID-19. New-onset embolic infarct, pulmonary edema was a contributor to the diagnosis of endocarditis in most patients. Involvement of the aortic valve was most common. Delayed diagnosis and cardiac surgery were contributors to increased morbidity.

Publication types

  • Review

MeSH terms

  • COVID-19* / complications
  • Coinfection*
  • Endocarditis* / complications
  • Endocarditis* / diagnosis
  • Endocarditis, Bacterial* / complications
  • Endocarditis, Bacterial* / diagnosis
  • Endocarditis, Bacterial* / surgery
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies